{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:41:10Z","timestamp":1786995670293,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H05445"],"award-info":[{"award-number":["JP16H05445"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K22676"],"award-info":[{"award-number":["JP19K22676"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.pharmthera.2020.107682","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T22:49:27Z","timestamp":1600469367000},"page":"107682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["RANKL as a key figure in bridging between the bone and immune system: Its physiological functions and potential as a pharmacological target"],"prefix":"10.1016","volume":"218","author":[{"given":"Masashi","family":"Honma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ikebuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107682_bb0005","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00198-013-2313-x","article-title":"NF-kappaB signaling and bone resorption","volume":"24","author":"Abu-Amer","year":"2013","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1105677","article-title":"Dependence of self-tolerance on TRAF6-directed development of thymic stroma","volume":"308","author":"Akiyama","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.immuni.2008.06.015","article-title":"The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance","volume":"29","author":"Akiyama","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fimmu.2012.00278","article-title":"TNF receptor family signaling in the development and functions of medullary thymic epithelial cells","volume":"3","author":"Akiyama","year":"2012","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0030","doi-asserted-by":"crossref","first-page":"44347","DOI":"10.1074\/jbc.M202009200","article-title":"A RANK\/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function","volume":"277","author":"Armstrong","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/35046196","article-title":"Bone versus immune system","volume":"408","author":"Arron","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0040","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0045","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1172\/JCI45913","article-title":"OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice","volume":"121","author":"Barrow","year":"2011","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0050","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1073\/pnas.0915148107","article-title":"Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland","volume":"107","author":"Beleut","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11914-017-0380-1","article-title":"Denosumab: An emerging therapy in pediatric bone disorders","volume":"15","author":"Boyce","year":"2017","journal-title":"Current Osteoporosis Reports"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fimmu.2012.00381","article-title":"Mesenchymal cell differentiation during lymph node organogenesis","volume":"3","author":"Brendolan","year":"2012","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0065","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/373531a0","article-title":"Expression of relB is required for the development of thymic medulla and dendritic cells","volume":"373","author":"Burkly","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00795-015-0099-y","article-title":"The osteocyte plays multiple roles in bone remodeling and mineral homeostasis","volume":"48","author":"Chen","year":"2015","journal-title":"Medical Molecular Morphology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41590-018-0128-9","article-title":"Thymic tolerance as a key brake on autoimmunity","volume":"19","author":"Cheng","year":"2018","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.critrevonc.2018.10.011","article-title":"RANK\/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment","volume":"133","author":"van Dam","year":"2019","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1074-7613(02)00423-5","article-title":"The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways","volume":"17","author":"Dejardin","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cytogfr.2004.03.011","article-title":"Ligands working as receptors: Reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system","volume":"15","author":"Eissner","year":"2004","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","article-title":"The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0105","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/abbs\/gmq086","article-title":"Osteogenic growth peptide enhances the proliferation of bone marrow mesenchymal stem cells from osteoprotegerin-deficient mice by CDK2\/cyclin A","volume":"42","author":"Fei","year":"2010","journal-title":"Acta Biochimica et Biophysica Sinica Shanghai"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0110","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","article-title":"Requirement for NF-kappaB in osteoclast and B-cell development","volume":"11","author":"Franzoso","year":"1997","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0115","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1074\/jbc.M112.426080","article-title":"Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-kappaB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity","volume":"288","author":"Furuya","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41467-017-02541-w","article-title":"Direct cell-cell contact between mature osteoblasts and osteoclasts dynamically controls their functions in vivo","volume":"9","author":"Furuya","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","article-title":"c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling","volume":"266","author":"Grigoriadis","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0130","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P","article-title":"RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse","volume":"30","author":"Heino","year":"2000","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12016-015-8521-8","article-title":"A comprehensive review of Immunoreceptor regulation of osteoclasts","volume":"51","author":"Humphrey","year":"2016","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","article-title":"Coupling of bone resorption and formation by RANKL reverse signalling","volume":"561","author":"Ikebuchi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0145","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2249.2009.03932.x","article-title":"Lymphoid tissue inducer cells: Architects of CD4 immune responses in mice and men","volume":"157","author":"Kim","year":"2009","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41467-019-13883-y","article-title":"Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity","volume":"11","author":"Kimura","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0160","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.4049\/jimmunol.0901563","article-title":"RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium","volume":"183","author":"Knoop","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0165","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.3389\/fimmu.2019.02345","article-title":"The roles of Peyer\u2019s patches and microfold cells in the gut immune system: Relevance to autoimmune diseases","volume":"10","author":"Kobayashi","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/imr.12398","article-title":"T-cell selection in the thymus: A spatial and temporal perspective","volume":"271","author":"Kurd","year":"2016","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0185","doi-asserted-by":"crossref","first-page":"8768162","DOI":"10.1155\/2016\/8768162","article-title":"Medication-related osteonecrosis of the jaw: New insights into molecular mechanisms and cellular therapeutic approaches","volume":"2016","author":"Lombard","year":"2016","journal-title":"Stem Cells International"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0190","doi-asserted-by":"crossref","first-page":"26475","DOI":"10.1074\/jbc.M313973200","article-title":"Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos","volume":"279","author":"Matsuo","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0200","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1073\/pnas.0401602101","article-title":"The immunomodulatory adapter proteins DAP12 and fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase","volume":"101","author":"Mocsai","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fimmu.2012.00261","article-title":"Emerging functions of RANKL in lymphoid tissues","volume":"3","author":"Mueller","year":"2012","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2443.1999.00265.x","article-title":"Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice","volume":"4","author":"Naito","year":"1999","journal-title":"Genes to Cells"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0215","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nature Medicine"},{"issue":"80\u201392","key":"10.1016\/j.pharmthera.2020.107682_bb0220","article-title":"Lymphatic endothelial cells control initiation of lymph node organogenesis","volume":"47","author":"Onder","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0225","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41232-019-0111-3","article-title":"RANKL biology: Bone metabolism, the immune system, and beyond","volume":"40","author":"Ono","year":"2020","journal-title":"Inflammation and Regeneration"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0230","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ni.1789","article-title":"Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation","volume":"10","author":"van de Pavert","year":"2009","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0235","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.immuni.2012.01.016","article-title":"Rank signaling links the development of invariant gammadelta T cell progenitors and Aire(+) medullary epithelium","volume":"36","author":"Roberts","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0240","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1084\/jem.20062497","article-title":"RANK signals from CD4(+)3(\u2212) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla","volume":"204","author":"Rossi","year":"2007","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0245","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0250","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/bies.201600104","article-title":"Peptide drugs accelerate BMP-2-induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling","volume":"38","author":"Sugamori","year":"2016","journal-title":"Bioessays"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0255","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cell.2015.10.013","article-title":"Fezf2 orchestrates a Thymic program of self-antigen expression for immune tolerance","volume":"163","author":"Takaba","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0260","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","article-title":"Osteoblastic cells are involved in osteoclast formation","volume":"123","author":"Takahashi","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0265","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Developmental Cell"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0270","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/ar1784","article-title":"The TRAF6-NF kappa B signaling pathway in autoimmunity: Not just inflammation","volume":"7","author":"Thomas","year":"2005","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0275","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(99)00210-0","article-title":"Osteoblasts\/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor\/RANKL but not macrophage colony-stimulating factor: Receptor activator of NF-kappa B ligand","volume":"25","author":"Udagawa","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0280","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2016.04.019","article-title":"The TNF receptor superfamily in co-stimulating and co-inhibitory responses","volume":"44","author":"Ward-Kavanagh","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0285","doi-asserted-by":"crossref","first-page":"28355","DOI":"10.1074\/jbc.273.43.28355","article-title":"The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor","volume":"273","author":"Wong","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0290","doi-asserted-by":"crossref","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","article-title":"TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells","volume":"272","author":"Wong","year":"1997","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0295","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0300","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107682_bb0305","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","article-title":"Skeletal remodeling in health and disease","volume":"13","author":"Zaidi","year":"2007","journal-title":"Nature Medicine"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820302126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820302126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:09:08Z","timestamp":1759010948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820302126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":61,"alternative-id":["S0163725820302126"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107682","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RANKL as a key figure in bridging between the bone and immune system: Its physiological functions and potential as a pharmacological target","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107682"}}